CIK 0000906709
- Non-accelerated filer
- Smaller reporting company
NEKTAR THERAPEUTICS
Sign in to watch- Ticker
- NKTR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943134940
- Phone
- +1 415-482-5300
- Business address
- 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
- Former names
- INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
- 4 Exercise or conversion Director acquired 12,500 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 10,200 shares (grant or award)
- 4 Grant or award Director acquired 10,200 shares (grant or award)
- 4 Grant or award Director acquired 10,200 shares (grant or award)
- 4 Open-market sale Director sold 3,665 shares at $17.78 ($65,164)
- 4 Open-market sale Director sold 4,600 shares at $17.94 ($82,524)
- 4 Open-market sale Director sold 3,665 shares at $17.78 ($65,164)
- 4 Exercise or conversion Director acquired 40,000 shares (option exercise)
- 4 Open-market sale Director sold 18,279 shares at an average $16.01 ($292,670)
- 4 Exercise or conversion Director acquired 45,000 shares (option exercise)
- 4 Gift Director gave 6,300 shares (gift)
- 4 Open-market sale Chief R&D Officer sold 7,662 shares at $13.83 ($105,965)
- 4 Open-market sale SVP & General Counsel sold 1,910 shares at $13.83 ($26,415)
- 4 Open-market sale President & CEO sold 11,515 shares at $13.83 ($159,252)
- 4 Open-market sale SVP & Chief Accounting Officer sold 13,339 shares at $13.83 ($184,478)
Page 8 of 49 · 968 filings